Assesment of Vitamin B6 Level in Patients With Major Depressive Disorder

Launched by ASSIUT UNIVERSITY · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is designed to study the levels of vitamin B6 in patients who have been recently diagnosed with major depressive disorder, which is a type of depression. The researchers want to understand if there is a connection between vitamin B6 levels and the severity of depression symptoms.

To participate in this trial, individuals must be at least 18 years old and have received a diagnosis of major depressive disorder. However, people with other psychiatric conditions or chronic medical issues will not be eligible. If you join the study, you will be asked to provide your consent and may undergo tests to measure your vitamin B6 levels and assess your depression symptoms. This trial is not yet recruiting participants, but it aims to gather important information that could help improve treatment for depression in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All participants must fulfill the following inclusion criteria;
• • 1. Patients diagnosed newly as major depressive disorder according to DSM-5( Diagnostic and Statistical Manual ) and (APA 2013) .
• • 2. Aged at least 18 years of both sex .
• • 3. Able to give informed consent .
• Exclusion Criteria:
• • 1. Patients have Comorbidity with other psychiatric disorders .
• • 2. Patients have chronic medical conditions , chronic debilitating or nutritional disorders .
• • 3. for control , Patients with any psychiatric disorders .